Fluoxetine in the treatment of borderline and schizotypal personality disorders.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 1853957.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty-two patients meeting the criteria for borderline or schizotypal personality disorder or both participated in a prospective, nonblind 12-week trial of fluoxetine. There were significant reductions in self-injury and in scores on the Hopkins Symptom Checklist regardless of diagnosis. The results suggest that controlled trials of fluoxetine and investigations of the serotonergic system in these disorders would be useful.
Medical subject headings
- Borderline Personality Disorder
- Fluoxetine
- Schizotypal Personality Disorder